1 min read

Meet the Team: Angie Bemis

By Matthew Bartolucci on 10/4/19 8:47 AM

AngieBemis October 4, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Twice a week, tune in to learn more about members of our team and see what they do inside and outside of work.


Angie Bemis

Research Associate

Q: What excites you about science?

A: The boundless possibilities.

Q: What is your favorite fun fact?

A: The reason that banana flavored foods don't taste like actual bananas is that the flavoring we use now was based on a strain on banana that went extinct in 1965.

Q: What do you do in your free time?

A: Play hockey and sleep

Q: What is the coolest thing you have done at Abveris or what is your favorite memory of working here?

A: I actually really like the "housekeeping" that comes with working at a small company. Moving desks, rearranging the lab, helping bring new equipment online, etc.

Topics: Team Updates
1 min read

Abveris to attend Festival of Biologics 2019 in Basel, Switzerland

By Matthew Bartolucci on 10/3/19 10:17 PM

Basel, CH - October 4, 2019 - Will you be at the Festival of Biologics conference in Switzerland this year? Meet with our Director of Business Development, Ryan Kelly, who will be presenting a posters about our proprietary therapeutic antibody discovery technologies.  See you there from October 15-17.

About Festival of Biologics:

The Festival of Biologics combines four outstanding conferences, the European Antibody Congress, the World Immunotherapy Congress, the World Biosimilar Congress and the Clinical Trials World Congress to make one amazing event.

With both a conference and exhibition, the show brings together industry leaders to meet, discuss and showcase their work in the biologics, biopharma and immunotherapy fields, just to name a few.

The Congress hosts high-level speakers hailing from big pharma, biotech, academia, regulatory bodies, investor groups, and associations, discussing topics representing key challenges within their industries, new data, case studies and research.

This year, presentations will move through the entire development pipeline and focus on commercial applications. The Festival of Biologics’ mission is to bring together the full value chains from the antibodies, immunotherapy, clinical trials and biosimilars industries together, located in Basel – a major life science hub.

Topics: Conferences
1 min read

Meet the Team: Haley Wagner

By Madeleine Carbonneau on 10/1/19 8:09 AM

HaleyWagner October 1, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Twice a week, tune in to learn more about members of our team and see what they do inside and outside of work.

Haley Wagner

Research Associate 

Q: What excites you about science?

A: I’m excited by how you can use science to help people and cure illnesses, the endless possibilities, the creativity aspect combined with the critical thinking aspect, understanding how things work, and discovering and learning new things constantly.

Q: What is your favorite fun fact?

A: Kindness is contagious.

Q: What do you do in your free time?

A: I like to cook, bake (and decorate), crafts and DIY, adventure with my chameleon, crossfit, run, hike, and explore state parks, blog, research/read about scientific topics and journal articles to improve my understanding and to be able to think of my own experiments, spend time with my Nana and Papa, guitar, hiking, biking, sell painted shells for charity, throw knives, and sew.

Q: What is the coolest thing you have done at Abveris or what is your favorite memory of working here?

A: It's really hard to choose just one. My favorite part of Abveris is working with such incredible people. I have a favorite memory with each person specifically, but my favorite memory as a group is the company party because I got to introduce my blood family to my work family. The coolest things I have done is a tie between getting the opportunity to attend and present at PEGS, getting to decorate the lab/office areas, when we troubleshoot and are able to get good sequence results from a difficult clone, and I'm extra excited about being able to contribute to develop ion channel antibodies.

Topics: Team Updates
1 min read

Meet the Team: Garren Hilow

By Matthew Bartolucci on 8/29/19 10:26 AM

GarrenHilow-1 August 29, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Tune in to learn more about members of our team and see what they do inside and outside of work.

Garren Hilow
CEO

Q: What excites you about science?

A: The direct application of biology to improve the health of people is very exciting and it's what we do here every day.

Q: Share a fun fact about you?

A: I once made extra money in college by selling balloon animals in the Downtown Crossing T station.

Q: What do you do in your free time?

A: I like to spend time with my wife and young son, mountain biking, and fishing.

Q: What is the coolest thing you have done at Abveris or what is your favorite memory of working here?

A: We have made a few antibodies that have gone on to be leads for our partners and have gone on to clinical trials. That direct application of our work to improving the health of our fellow humans is the coolest work I've done in my life.

Topics: Team Updates
1 min read

CSO of Abveris, Colby Souders, Ph.D., to Present at Discovery On Target 2019

By Ryan Kelly on 8/22/19 9:07 AM

August 22, 2019 – Boston, MA – Representatives from Abveris will attend the 17th Annual Discovery On Target Conference, September 16-19, 2019, in Boston, MA. Colby Souders, Chief Scientific Officer of Abveris, will serve as chairperson for the Antibody Engineering and Development Forum and present "Screening Tools for Early Prediction of Development and Clinical Success" at 3:40PM on Thursday, September 19. An abstract for the presentation is listed below.

Click here to schedule an appointment with the Abveris team during the conference.

Abstract: As industry-wide advancements in antibody drug discovery continue to push toward larger panels of candidates for early-stage characterization, more efficient identification of lead molecules through enhanced screening resolution is required. Integrating tools and methods into the overall characterization workflow enables reliable, high throughput selection of lead candidates more effectively than alternative traditional techniques. Comparisons across platforms, including traditional ELISA, flow cytometry, Octet and in vivo studies will be presented that provide enhanced prediction of downstream development and clinical success.

About Discovery On Target: The 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.

Topics: Team Updates Conferences
1 min read

Meet the Team: Radha Subburathinam

By Matthew Bartolucci on 8/19/19 10:07 AM

RadhaSubburathinam August 19, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Twice a week, tune in to learn more about members of our team and see what they do inside and outside of work.

Radha Subburathinam

Senior Research Associate

Q: What excites you about science?

A: It answers my questions - have a question, design an experiment, analyze the data, find your answer - science is as simple as that and its explainable.

Q: What is your favorite fun fact?

A: My daughter is a gummy bear-eating champ.

Q: What do you do in your free time?

A: I like to call and talk to my friends.

Q: What is the coolest thing you have done at Abveris or what is your favorite memory of working here?

A: I really enjoyed baking with my friends for PEGS - it was really a fun day.

 

Topics: Team Updates
1 min read

Abveris and Geneious Biologics Collaborate to Advance Antibody NGS Data Analysis

By Travis LeGuyader on 8/12/19 8:01 AM

Canton, MA, USA – August 12, 2019 – Boston-based antibody discovery services company Abveris has partnered with Biomatters to incorporate the Geneious Biologics data analysis platform into their antibody discovery workflow. In collaboration, a new Single Clone Antibody Annotator pipeline has been developed.

With a rapidly growing customer base and a wide range of antibody discovery services, Abveris plans to leverage the Geneious Biologics platform as a premium hub for bioinformatics and computer programming capabilities.

"The Geneious team has done an excellent job accommodating our specific data resulting in a streamlined, high-throughput workflow that produces accurate data and operates efficiently without the need to integrate multiple bioinformatics platforms," remarked Dr. Colby Souders, Chief Technology Officer at Abveris. "We look forward to continuously improving the platform and its integration into our workflow to combine sequence analytics with metadata and assay data to accelerate candidate selection."

The Geneious team worked closely with Abveris to optimize and enhance the handling of their antibody NGS data. Jannick Bendtsen, VP Technology Services at Geneious, commented, "Abveris is at the cutting edge of antibody drug discovery; they are pushing the boundaries of science and technology. To have Colby and the team select Geneious Biologics is a great honor and a great compliment. We collaborated to integrate our Single Clone Antibody Annotator Pipeline, and it now runs out of the box. It's all about speed and accuracy in the discovery process."

About Abveris: Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms, including the proprietary DiversimAb™ hyperimmune mouse technology. Additional information about Abveris is available at https://www.abveris.com.

About Geneious and Biomatters: Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering, and advanced comparative analysis of DNA, RNA, and protein sequences. Geneious solutions are created from a deep understanding of customer experience to turn the difficult into the intuitive and easy. Geneious is trusted by over 4,000 companies, universities, and institutes all over the globe. Additional information about Geneious is available at https://www.geneious.com.

Topics: Press Releases Service & Product Updates
1 min read

Meet the Team: Jen Walker

By Madeleine Carbonneau on 8/6/19 10:30 AM

JenWalker August 6, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Twice a week, tune in to learn more about members of our team and see what they do inside and outside of work.

Jen Walker 

Associate Director of Antibody Discovery Operations 

 

Q: What excites you about science?

A: Science helps us interrogate and understand our world, and by its very nature uncovers more questions with each answer. What could be cooler than that?!

 

Q: What is your favorite fun fact?

A: Honey bees must gather nectar from two million flowers to make one pound of honey.



Q: What do you do in your free time?

A: In my free time I spend time with my family and friends, work in my gardens, and volunteer as an advocate for individuals and families affected by Alzheimer's Disease.

 

Q: What is the coolest thing you have done at Abveris or what is your favorite memory of working here?

A: I am very new to Abveris but it's already been a lot of fun! Here's a shout-out to the arrival of the Beacon, the barbeques, hibachi lunches and the on-going Corn Hole tournament (which has proved itself to be epic).

Topics: Team Updates
1 min read

Abveris and Lava Therapeutics Announce Antibody Discovery Collaboration

By Madeleine Carbonneau on 7/29/19 9:01 AM

Canton, MA, July 29, 2019 - Abveris, Inc., a leader in contract research antibody discovery, today announced that it has entered into a collaborative agreement with Lava Therapeutics BV, a biopharmaceutical company developing next-generation T cell engager therapies. Under the terms of the agreement, Abveris will leverage its proprietary technology to develop critical reagent antibodies to support assay development for bispecific antibody γδ T cell engagers selected by Lava Therapeutics.

“The Abveris team is pleased to be working with Lava to accelerate the path to clinical development for their lead compound,” commented Ryan Kelly, Director of Business Development at Abveris. “We apply our proprietary hyperimmune platform to deliver consistent results for diverse biotherapeutic molecule formats. We look forward to working with the Lava Therapeutics team to help advance their γδ T cell engaging bispecific molecules.”

“We are delighted to enter a collaboration with Abveris on the generation of high-quality antibodies as critical reagents in our drug development programs of bispecific γδ T cell engagers. The use of the Abveris hyperimmune platform will enable the accelerated development of advanced (non-)clinical assays for our programs.” said Ton Adang, Senior VP and CDO of Lava Therapeutics B.V.

About Abveris: Abveris is a premium Boston-area contract research organization specializing in antibody discovery. Abveris partners with large and small biopharmaceutical companies to discover novel therapeutic products and critical reagent antibodies using diverse platforms, including the proprietary DiversimAb™ hyperimmune mouse technology. Additional information about Abveris is available at www.abveris.com.

About Lava Therapeutics: Lava Therapeutics’ proprietary platform is focused on developing next-generation γδ T cell engaging bispecific antibodies to treat cancer. Lava’s vision is to develop therapeutics for the curative treatment of cancer. For more information, please visit www.lavatherapeutics.com.

 

Contact for Abveris:

Garren Hilow

contact@abverisantibody.com

+1 781-562-1170

Contact for Lava Therapeutics:

Erik Ensing

e.ensing@lavatherapeutics.com

Topics: Press Releases
1 min read

Meet the Team: Justin Gabriel

By Matthew Bartolucci on 7/24/19 10:30 AM

 


Justin Gabriel 

Research Associate - Lead TC

July 24, 2019 - Our team is comprised of creative, friendly, mission-focused antibody enthusiasts who take pride in discovery science. This summer, Abveris will be featuring all of our team members on our blog to showcase the personalities that make our team a community. Twice a week, tune in to learn more about members of our team and see what they do inside and outside of work.JustinGabriel

 

Q: What excites you about science?

A: It never ends! I think the most fascinating aspect of science is the fact that we've been studying the world around us for so long and there's still an unfathomably immense amount of ground to cover.

 

Q: What is your favorite fun fact?

A: Under normal atmospheric pressure/conditions (on Earth), water molecules move from their liquid to gaseous phase at ~720 m/s!!!

 

Q: What do you do in your free time?

A: Everything! Racing drones, ride my motorcycle, work on my car, disc golf, going to the gym. I'd try almost anything once!

 

Q: What is the coolest thing you have done at Abveris/what is your favorite memory of working here?

A: I believe the"coolest" aspect of working here at Abveris is getting exposure to all different aspects of antibody production while getting the opportunity to work alongside some amazing people. I truly do love coming to work everyday and am very grateful for every opportunity this company has given me.

Featured